The cross-species mycobacterial growth inhibition assay (MGIA) project 2010-2014
The development of a functional biomarker assay in the tuberculosis (TB) field would be widely recognized as a major advance in efforts to efficiently develop and test novel TB vaccine candidates. We present preliminary studies using mycobacterial growth inhibition assays (MGIAs) to detect a BCG vac...
主要な著者: | Brennan, M, Tanner, R, Morris, S, Scriba, T, Achkar, J, Zelmer, A, Hokey, D, Izzo, A, Sharpe, S, Williams, A, Penn-Nicholson, A, Erasmus, M, Stylianou, E, Hoft, D, McShane, H, Fletcher, H |
---|---|
フォーマット: | Journal article |
出版事項: |
American Society for Microbiology
2017
|
類似資料
-
Assessment of the reproducibility and inter-site transferability of the murine direct splenocyte mycobacterial growth inhibition assay (MGIA)
著者:: Tanner, R, 等
出版事項: (2021) -
A mycobacterial growth inhibition assay (MGIA) for bovine TB vaccine development
著者:: Pepponi, I, 等
出版事項: (2017) -
A new tool for tuberculosis vaccine screening: Ex vivo Mycobacterial Growth Inhibition Assay indicates BCG mediated protection in a murine model of tuberculosis
著者:: McShane, H, 等
出版事項: (2016) -
Demonstrating the utility of the ex vivo murine mycobacterial growth inhibition assay (MGIA) for high-throughput screening of tuberculosis vaccine candidates against multiple Mycobacterium tuberculosis complex strains
著者:: Painter, H, 等
出版事項: (2024) -
The in vitro direct mycobacterial growth inhibition assay (MGIA) for the early evaluation of TB vaccine candidates and assessment of protective immunity: a protocol for non-human primate cells
著者:: Tanner, R, 等
出版事項: (2021)